Streptomyces clavuligerus
(NCBI:txid1901)
|
See:
PubMed
|
antibacterial drug
A drug used to treat or prevent bacterial infections.
bacterial metabolite
Any prokaryotic metabolite produced during a metabolic reaction in bacteria.
EC 3.5.2.6 (beta-lactamase) inhibitor
An EC 3.5.2.* (non-peptide cyclic amide C-N hydrolase) inhibitor that interferes with the action of beta-lactamase (EC 3.5.2.6).
|
|
antibacterial drug
A drug used to treat or prevent bacterial infections.
anxiolytic drug
Anxiolytic drugs are agents that alleviate anxiety, tension, and anxiety disorders, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions.
|
|
(2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
|
(2R,3Z,5R)-3-(2-HYDROXYETHYLIDENE)-7-OXO-4-OXA-1-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLIC ACID
|
PDBeChem
|
(Z)-(2R,5R)-3-(2-Hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo(3.2.0)heptane-2-carboxylic acid
|
ChemIDplus
|
antibiotic MM 14151
|
ChemIDplus
|
Clavulanate
|
KEGG COMPOUND
|
Clavulanic acid
|
KEGG COMPOUND
|
Clavulansäure
|
ChemIDplus
|
clavulonic acid
Note: (2015-04-15) A rare variant spelling. |
|
ChEBI
|
MM 14151
|
ChemIDplus
|
58001-44-8
|
CAS Registry Number
|
KEGG COMPOUND
|
58001-44-8
|
CAS Registry Number
|
ChemIDplus
|
58001-44-8
|
CAS Registry Number
|
DrugBank
|
787059
|
Beilstein Registry Number
|
Beilstein
|
787059
|
Reaxys Registry Number
|
Reaxys
|